Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease

• Published in: Frontiers in aging neuroscience Vol. 12; p. 594432
• Main Authors: Wang, Liao-Yao, Pei, Jian, Zhan, Yi-Jun, Cai, Yi-Wen
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Research Foundation 25.11.2020; Frontiers Media S.A
• Subjects: Activities of daily living; Acupuncture; Alzheheimer's disease; Alzheimer's disease; Clinical trials; Cognitive ability; Dementia; effectiveness; Exercise; Intervention; Magnetic fields; Medical research; Memory; Meta-analysis; Music therapy; Neurodegenerative diseases; Neuroscience; non-pharmacological intervention; overview; Physical fitness; Quality control; Transcranial magnetic stimulation; effectiveness; overview; meta–analysis; non-pharmacological intervention; Alzheheimer's disease
• ISSN: 1663-4365; 1663-4365
• DOI: 10.3389/fnagi.2020.594432

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive memory deficits, cognitive decline, and spatial disorientation. Non-pharmacological interventions to treat AD have been reported in many meta-analyses (MAs), but robust conclusions have not been made because of variations in the scope, quality, and findings of these reviews. This work aimed to review existing MAs to provide an overview of existing evidence on the effects of five non-pharmacological interventions in AD patients on three outcomes: Mini-Mental State Examination (MMSE), activities of daily living (ADL), and Alzheimer's Disease Assessment Scale-cognitive section (ADAS-cog). The databases PubMed, Cochrane Library, Embase, and Web of Science were searched to collect MAs of non-pharmacological interventions for AD. Two reviewers independently conducted literature screening, data extraction, and quality assessment. We assessed the quality of MAs with the Measurement Tool to Assess Systematic Reviews (AMSTAR) 2 and assessed the evidence quality for significant outcomes using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. We found 10 eligible MAs, which included between three (133 patients) and 15 randomized trials (1,217 patients), and five non-pharmacological interventions, namely, acupuncture therapy (40%), exercise intervention (30%), music therapy (10%), cognitive intervention (10%), and repetitive transcranial magnetic stimulation (rTMS) (10%). All the included MAs were critically low to low quality by AMSTAR 2. Acupuncture therapy and exercise intervention showed the preliminary potential to improve ADL and MMSE. rTMS and acupuncture therapy show benefits in decreasing ADAS-cog, and there were some evidence of improved MMSE with cognitive intervention. All these outcomes scored very low quality to moderate quality of evidence on the GRADE system. Non-pharmacological therapy shows promise for the treatment of AD, but there is still a lack of high-quality evidence. In the future, the quality of the original research needs to be improved, and strictly designed MAs should be carried out following methodological requirements.